SCTX · Scribe Therapeutics, Inc. · Suppliers & Customers
$17.05
+0.85 (+5.25%)
At close · Nov 4
Return incl. dividend (before tax)
Going-concern doubt
— cleared Sep 2, 2026
The latest filing states the doubt was alleviated.
“Substantial doubt about our ability to continue as a going concern existed as of June 30, 2026 and was alleviated as a result of the completion of our initial public offering and concurrent private placement, which resulted in aggregate net proceeds of approximately $140.7 million.”View the 10-Q filed Sep 2, 2026
Market Cap
$320.27M
Shares
18.93M
Volume · Nov 4
204.03K
Avg daily vol (3M)
375.75K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Supply Chain
Customers, suppliers, competitors and partners, private companies included: the ones SCTX names, and the companies that name SCTX.
Read supply chains in your AI or your code through MCP and the API →
Pro
See who SCTX sells to, buys from and competes with
- 0 suppliers
- 0 customers
- 4 competitors
Pro names each company, links it to its own page, shows any revenue share the filing states, and quotes the sentence it comes from.